These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26044781)

  • 1. Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia.
    Hillebrand J; Sindermann J; Schmidt C; Mesters R; Martens S; Scherer M
    J Artif Organs; 2015 Dec; 18(4):291-9. PubMed ID: 26044781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abciximab/Heparin Therapy for Left Ventricular Assist Device Implantation in Patients With Heparin-Induced Thrombocytopenia.
    Lee CL; Colombo PC; Eisenberger A; Diuguid D; Jennings DL; Han J; Salna MP; Takeda K; Kurlansky PA; Yuzefpolskaya M; Garan AR; Naka Y; Takayama H
    Ann Thorac Surg; 2018 Jan; 105(1):122-128. PubMed ID: 28987395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
    Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia.
    Gernhofer YK; Ross M; Khoche S; Pretorius V
    J Cardiothorac Surg; 2018 Apr; 13(1):30. PubMed ID: 29665860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case series describing the use of argatroban in patients on extracorporeal circulation.
    Cornell T; Wyrick P; Fleming G; Pasko D; Han Y; Custer J; Haft J; Annich G
    ASAIO J; 2007; 53(4):460-3. PubMed ID: 17667231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HeartMate II implantation in patients with heparin-induced thrombocytopenia type II.
    Meyer AL; Malehsa D; Kuehn C; Bara C; Gras C; Hafer C; Haverich A; Strüber M
    Ann Thorac Surg; 2009 Aug; 88(2):674-5. PubMed ID: 19632444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of a pediatric patient on the Berlin Heart Excor ventricular assist device with argatroban after heparin-induced thrombocytopenia.
    Schmitz ML; Massicotte P; Faulkner SC; Bhutta AT; Johnson CE; Seib PM; Frazier EA; Fiser WP; Imamura M; Jaquiss RD
    ASAIO J; 2008; 54(5):546-7. PubMed ID: 18812751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
    Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
    Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified technique for implantation of the HeartWare™ left ventricular assist device when using bivalirudin anticoagulation in patients with acute heparin-induced thrombocytopenia.
    Morshuis M; Boergermann J; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2013 Aug; 17(2):225-6. PubMed ID: 23628649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device].
    Lutz JT; Exner HJ; Schannewitzky A; Fehske W; Görlinger K
    Anaesthesist; 2008 Jan; 57(1):49-52. PubMed ID: 18209967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
    Bartholomew JR; Pietrangeli CE; Hursting MJ
    Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
    Guzzi LM; McCollum DA; Hursting MJ
    J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
    Hellwig TR; Peitz GJ; Gulseth MP
    Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Eptifibatide Alone or in Combination With Heparin or Argatroban for Suspected Thrombosis in Patients With Left Ventricular Assist Devices.
    Bitar A; Vijayakrishnan R; Lenneman A; Birks E; Massey T; Slaughter M; Abramov D
    Artif Organs; 2017 Dec; 41(12):1092-1098. PubMed ID: 28621461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation.
    Eisenberger J; Somer S; Ram E; Nachum E; Frogal J; Levin S; Lavee J; Sternik L; Morgan J
    Isr Med Assoc J; 2023 Nov; 25(11):757-759. PubMed ID: 37980622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    Laliberte B; Reed BN
    Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.